Abstract
Background: Myanmar declared leprosy elimination in 2003. In 2018, the country reported 2,214 new leprosy cases of whom 263 had Grade-2 disability (G2D). The country aims to reduce new cases with G2D to <53 cases by 2023 through early diagnosis and treatment. Objectives: To describe the trends (actual and projected) in new leprosy cases from 2004 to 2023 and to explore the reasons for delay in diagnosis. Methods: Mixed-methods study. The quantitative part—ecological study using numbers of new leprosy cases from 2004–2018. For qualitative part, new cases with G2D and health care providers were interviewed. Results: The annual total new cases, new multibacillary cases, new cases with G2D, new child cases are showing a declining trend. Total new cases and new cases with G2D, between 2004 and 2018 have declined by 40% and 28% respectively. If the current trends continue there will be 1,785 (95% CI: 1546-2024) new cases and <53 new cases with G2D in 2023. The interviews of patients and providers yielded the following reasons for delay in diagnosis: incorrect knowledge about leprosy, delay in recognition of symptoms, inappropriate care seeking, and fear of stigma and discrimination. Reduction in health system efforts, lack of local leadership, human resource constraints and decreased funding also contributed to delay in diagnosis. Conclusions: The declining trends and the possibility of achieving the target for new cases with G2D by 2023 is encouraging. The country must address the challenges mentioned by patients and health care providers as a priority, to accelerate the decline in new cases.
Highlights
Leprosy is a curable, chronic, deforming infectious disease caused by the bacterium, Mycobacterium leprae.[1]
Due to advancements in the knowledge on prevention, clinical diagnosis and treatment, accompanied by improvements in health systems and socio-economic status, by the end of the 20th century, leprosy was eliminated as a public health problem at the global level.[1]
The annual total number of new leprosy cases has declined by about 40% from 3,756 cases in 2004 to 2,214 cases by 2018
Summary
Chronic, deforming infectious disease caused by the bacterium, Mycobacterium leprae.[1]. Due to advancements in the knowledge on prevention, clinical diagnosis and treatment, accompanied by improvements in health systems and socio-economic status, by the end of the 20th century, leprosy was eliminated as a public health problem at the global level (elimination as a public health problem was defined as prevalence of
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
